Outcomes of COVID-19 infection in multiple sclerosis and related conditions: One-year pandemic experience of the multicenter New York COVID-19 Neuroimmunology Consortium (NYCNIC)
Sylvia Klineova, Asaff Harel, Rebecca Straus Farber, Tracy M. DeAngelis, Yinan Zhang, Roland Hentz, Tung Ming Leung, Kathryn T. Fong, Tyler Smith, Richard Blanck, Lana Zhovtis Ryerson
Topics & Concepts
Coronavirus disease 2019 (COVID-19)PandemicMedicineMultiple sclerosisNeuroimmunology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMulticenter studyImmunologyDiseaseInfectious disease (medical specialty)Internal medicineImmune systemOutbreakRandomized controlled trialLong-Term Effects of COVID-19Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders